Get Started

PCYC

(MM) (PCYC)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PCYC

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
05/26/2015	7:23AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:22AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:20AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:18AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:16AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:13AM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PCYC	(MM)
05/26/2015	7:10AM	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:PCYC	(MM)
05/22/2015	8:46AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PCYC	(MM)
05/22/2015	8:04AM	PR Newswire (US)	European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's...	NASDAQ:PCYC	(MM)
05/21/2015	8:35AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PCYC	(MM)
05/20/2015	10:06AM	The Motley Fool	SWOT Analysis of Gilead Sciences Inc. Stock	NASDAQ:PCYC	(MM)
05/15/2015	5:04PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PCYC	(MM)
05/14/2015	9:02AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PCYC	(MM)
05/14/2015	8:58AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PCYC	(MM)
05/13/2015	5:21PM	PR Newswire (US)	New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:PCYC	(MM)
05/08/2015	5:05PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PCYC	(MM)
05/07/2015	4:11PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PCYC	(MM)
05/05/2015	5:56PM	Dow Jones News	AbbVie Wraps Up Large Debt Sale for Pharmacyclics Deal	NASDAQ:PCYC	(MM)
05/05/2015	5:38PM	Dow Jones News	AbbVie Wraps Up Large Debt Sale For Pharmacyclics Deal	NASDAQ:PCYC	(MM)
05/05/2015	2:40PM	Dow Jones News	AbbVie Launches Large Debt Sale for Pharmacyclics Deal	NASDAQ:PCYC	(MM)
05/05/2015	2:24PM	Dow Jones News	AbbVie Launches Large Debt Sale for Pharmacyclics Deal	NASDAQ:PCYC	(MM)
05/05/2015	9:38AM	Analyst Ratings Network	Zacks Lowers Pharmacyclics to Hold (PCYC)	NASDAQ:PCYC	(MM)
05/04/2015	5:09PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PCYC	(MM)
05/04/2015	10:27AM	Analyst Ratings Network	Pharmacyclics Lifted to "Buy" at Zacks (PCYC)	NASDAQ:PCYC	(MM)
05/01/2015	6:58PM	Dow Jones News	AbbVie Extends Exchange Offer to Acquire Pharmacyclics	NASDAQ:PCYC	(MM)
05/01/2015	5:13PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PCYC	(MM)
05/01/2015	5:11PM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PCYC	(MM)
05/01/2015	9:15AM	PR Newswire (US)	Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates	NASDAQ:PCYC	(MM)
04/24/2015	9:43AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PCYC	(MM)
04/23/2015	5:26PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PCYC	(MM)